Thomas Papoian

1.3k total citations
20 papers, 954 citations indexed

About

Thomas Papoian is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Thomas Papoian has authored 20 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 4 papers in Oncology. Recurrent topics in Thomas Papoian's work include Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer Treatment and Pharmacology (3 papers). Thomas Papoian is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (6 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Cancer Treatment and Pharmacology (3 papers). Thomas Papoian collaborates with scholars based in United States and Thailand. Thomas Papoian's co-authors include William Lewis, Anne Chomyn, B. Gonzalez, Baichun Yang, Xi Yang, Eugene H. Herman, Kazuyo Takeda, Steven E. Lipshultz, V J Ferrans and Jun Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Reviews Drug Discovery and Biochemical and Biophysical Research Communications.

In The Last Decade

Thomas Papoian

20 papers receiving 924 citations

Peers

Thomas Papoian
Jean Michel Petit France
Anusha Ande United States
Giancarlo Ghiselli United States
Arturo Lopez‐Anaya United States
Kentaro Watanabe Japan
Hernando León Canada
Jonathan Q. Tran United States
Fang Zhao China
Rui Benfeitas Sweden
K. Christiansen Denmark
Jean Michel Petit France
Thomas Papoian
Citations per year, relative to Thomas Papoian Thomas Papoian (= 1×) peers Jean Michel Petit

Countries citing papers authored by Thomas Papoian

Since Specialization
Citations

This map shows the geographic impact of Thomas Papoian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Papoian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Papoian more than expected).

Fields of papers citing papers by Thomas Papoian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Papoian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Papoian. The network helps show where Thomas Papoian may publish in the future.

Co-authorship network of co-authors of Thomas Papoian

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Papoian. A scholar is included among the top collaborators of Thomas Papoian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Papoian. Thomas Papoian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hinderling, Peter H. & Thomas Papoian. (2020). Why Collecting Pharmacokinetic Information After Intravenous Drug Administration Is Important. Clinical Pharmacology in Drug Development. 9(2). 146–150. 3 indexed citations
2.
Zhang, Jun, Lijun Ren, Xi Yang, et al.. (2018). Cytotoxicity of 34 FDA approved small-molecule kinase inhibitors in primary rat and human hepatocytes. Toxicology Letters. 291. 138–148. 23 indexed citations
3.
Yang, Baichun & Thomas Papoian. (2018). Preclinical approaches to assess potential kinase inhibitor‐induced cardiac toxicity: Past, present and future. Journal of Applied Toxicology. 38(6). 790–800. 15 indexed citations
4.
5.
Papoian, Thomas, et al.. (2017). Safety of antisense oligonucleotide and siRNA-based therapeutics. Drug Discovery Today. 22(5). 823–833. 209 indexed citations
6.
Papoian, Thomas, Gowraganahalli Jagadeesh, Muriel Saulnier, et al.. (2017). Regulatory Forum Review*: Utility ofin VitroSecondary Pharmacology Data to Assess Risk of Drug-induced Valvular Heart Disease in Humans: Regulatory Considerations. Toxicologic Pathology. 45(3). 381–388. 23 indexed citations
7.
Zhang, Jun, Alec T. Salminen, Xi Yang, et al.. (2016). Effects of 31 FDA approved small-molecule kinase inhibitors on isolated rat liver mitochondria. Archives of Toxicology. 91(8). 2921–2938. 74 indexed citations
8.
Papoian, Thomas, Haw-Jyh Chiu, Ikram Elayan, et al.. (2015). Secondary pharmacology data to assess potential off-target activity of new drugs: a regulatory perspective. Nature Reviews Drug Discovery. 14(4). 294–294. 47 indexed citations
9.
Yang, Baichun & Thomas Papoian. (2012). Tyrosine kinase inhibitor (TKI)‐induced cardiotoxicity: approaches to narrow the gaps between preclinical safety evaluation and clinical outcome. Journal of Applied Toxicology. 32(12). 945–951. 43 indexed citations
10.
Zhang, Jun, Eugene H. Herman, Alan Knapton, et al.. (2002). SK&F 95654-Induced Acute Cardiovascular Toxicity in Sprague-Dawley Rats—Histopathologic, Electron Microscopic, and Immunohistochemical Studies. Toxicologic Pathology. 30(1). 28–40. 32 indexed citations
11.
Herman, Eugene H., Steven E. Lipshultz, Nader Rifai, et al.. (1998). Use of cardiac troponin T levels as an indicator of doxorubicin-induced cardiotoxicity.. PubMed. 58(2). 195–7. 116 indexed citations
12.
Lewis, William, B. Gonzalez, Anne Chomyn, & Thomas Papoian. (1992). Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria.. Journal of Clinical Investigation. 89(4). 1354–1360. 162 indexed citations
13.
Papoian, Thomas & William Lewis. (1992). Anthracyclines selectively decrease alpha cardiac actin mRNA abundance in the rat heart.. PubMed. 141(5). 1187–95. 5 indexed citations
14.
Papoian, Thomas & William Lewis. (1991). Selective alterations in rat cardiac mRNA induced by doxorubicin: Possible subcellular mechanisms. Experimental and Molecular Pathology. 54(2). 112–121. 10 indexed citations
15.
Lewis, William, et al.. (1991). Mitochondrial ultrastructural and molecular changes induced by zidovudine in rat hearts.. PubMed. 65(2). 228–36. 108 indexed citations
16.
Papoian, Thomas & William Lewis. (1990). Adriamycin cardiotoxicity in vivo. Selective alterations in rat cardiac mRNAs.. PubMed. 136(6). 1201–7. 20 indexed citations
17.
Hwang, David, Arye Lev-Ran, Thomas Papoian, & Walter Beech. (1987). Insulin-like activity of chromium-binding fractions from brewer's yeast. Journal of Inorganic Biochemistry. 30(3). 219–225. 19 indexed citations
18.
19.
Papoian, Thomas, et al.. (1984). Ethanolamine mimics insulin effects invitro. Biochemical and Biophysical Research Communications. 121(1). 413–419. 5 indexed citations
20.
Khwaja, Tasneem A., et al.. (1981). Studies on cytotoxic and immunologic effects of viscum album (mistletoe). Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 253. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jean Michel Petit Breakdown of academic impact, for papers by Anusha Ande Breakdown of academic impact, for papers by Giancarlo Ghiselli Breakdown of academic impact, for papers by Arturo Lopez‐Anaya Breakdown of academic impact, for papers by Kentaro Watanabe Breakdown of academic impact, for papers by Hernando León Breakdown of academic impact, for papers by Jonathan Q. Tran Breakdown of academic impact, for papers by Fang Zhao Breakdown of academic impact, for papers by Rui Benfeitas Breakdown of academic impact, for papers by K. Christiansen
Rankless by CCL
2026